Drug intelligence / Profile preview

astragalus + zedoary

Development stage
Unknown
Lead developer
Second Affiliated Hospital of Anhui University of Traditional Chinese Medicine
Administration
Oral
01

Overview

Astragalus and Zedoary is a Traditional Chinese Medicine (TCM) herbal combination consisting of the roots of *Astragalus membranaceus* (Huangqi) and the rhizomes of *Curcuma zedoaria* (Ezhu). This herb pair is frequently utilized in TCM for its synergistic effects in tonifying Qi and invigorating blood to remove stasis. In the context of oncology and gastroenterology, it is investigated for its potential to inhibit the progression of precancerous gastric lesions, such as gastric atrophy and intestinal metaplasia, to gastric cancer. The mechanism involves immunomodulation, inhibition of cell proliferation, induction of apoptosis, and regulation of the tumor microenvironment.

Other names
astragalus and zedoary granulesHuangqi-EzhuHuangqi and Ezhu
02

Targets

CXCR4 (C-X-C motif chemokine receptor 4)GSK3 (Glycogen synthase kinase 3 beta)JNK (Mitogen-activated protein kinase kinase kinase family)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)ARF6 (ADP-ribosylation factor 6)CDH2 (N-cadherin)WNT5A (Protein Wnt-5a)CTNNB1 (Beta-catenin)

Beyond the preview

Go deeper on astragalus + zedoary.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on astragalus + zedoary.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call